When PD-1 and VISTA genes, were assessed, the results showed that glioma patients who expressed high levels of PD-1 and high levels of VISTA presented a poorer survival compared to those who expressed lower levels (p < 0.0001) (p = 0.0078) (Figure 6B). This evidence concerns the gene PDCD1 and glioma.